AMPK alterations in cardiac physiology and pathology: enemy or ally?
暂无分享,去创建一个
[1] D. Hardie,et al. AMP-Activated Protein Kinase , 2017, Encyclopedia of Molecular Pharmacology.
[2] J. Dyck,et al. Activation of cardiac AMP-activated protein kinase by LKB1 expression or chemical hypoxia is blunted by increased Akt activity. , 2006, American journal of physiology. Heart and circulatory physiology.
[3] J. Schneider,et al. Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome. , 2006, American journal of physiology. Heart and circulatory physiology.
[4] M. Crompton,et al. Bax translocates to mitochondria of heart cells during simulated ischaemia: involvement of AMP-activated and p38 mitogen-activated protein kinases. , 2006, The Biochemical journal.
[5] Miao Zhang,et al. Activation of Protein Kinase Cζ by Peroxynitrite Regulates LKB1-dependent AMP-activated Protein Kinase in Cultured Endothelial Cells* , 2006, Journal of Biological Chemistry.
[6] D. Vertommen,et al. Insulin Antagonizes Ischemia-induced Thr172 Phosphorylation of AMP-activated Protein Kinase α-Subunits in Heart via Hierarchical Phosphorylation of Ser485/491* , 2006, Journal of Biological Chemistry.
[7] S. Vatner,et al. H11 Kinase Prevents Myocardial Infarction by Preemptive Preconditioning of the Heart , 2006, Circulation research.
[8] Anindya Dutta,et al. Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPK (cid:1) 2 but not AMPK (cid:1) 1 , 2006 .
[9] Ferhaan Ahmad,et al. Increased &agr;2 Subunit–Associated AMPK Activity and PRKAG2 Cardiomyopathy , 2005, Circulation.
[10] M. Sajan,et al. Insulin signalling downstream of protein kinase B is potentiated by 5′AMP-activated protein kinase in rat hearts in vivo , 2005, Diabetologia.
[11] J. Ninomiya-Tsuji,et al. AMP-Activated Protein Kinase Activates p38 Mitogen-Activated Protein Kinase by Increasing Recruitment of p38 MAPK to TAB1 in the Ischemic Heart , 2005, Circulation research.
[12] TomoichiroAsano,et al. Adenosine Monophosphate-Activated Protein Kinase Suppresses Vascular Smooth Muscle Cell Proliferation Through the Inhibition of Cell Cycle Progression , 2005 .
[13] T. Asano,et al. Adenosine Monophosphate-Activated Protein Kinase Suppresses Vascular Smooth Muscle Cell Proliferation Through the Inhibition of Cell Cycle Progression , 2005, Circulation research.
[14] S. Kihara,et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2–dependent mechanisms , 2005, Nature Medicine.
[15] T. Funahashi,et al. Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism. , 2005, Cardiovascular research.
[16] J. Seidman,et al. N488I Mutation of the γ2-Subunit Results in Bidirectional Changes in AMP-Activated Protein Kinase Activity , 2005 .
[17] Ferhaan Ahmad,et al. Functional role of AMP‐activated protein kinase in the heart during exercise , 2005, FEBS letters.
[18] G. Dorn,et al. Protein kinase cascades in the regulation of cardiac hypertrophy. , 2005, The Journal of clinical investigation.
[19] L. Witters,et al. Dual Mechanisms Regulating AMPK Kinase Action in the Ischemic Heart , 2005, Circulation research.
[20] G. Lopaschuk,et al. Myocardial Ischemia Differentially Regulates LKB1 and an Alternate 5′-AMP-activated Protein Kinase Kinase* , 2005, Journal of Biological Chemistry.
[21] J. Balschi,et al. Hypoxia and AMP independently regulate AMP-activated protein kinase activity in heart. , 2005, American journal of physiology. Heart and circulatory physiology.
[22] G. Taffet,et al. Transgenic Mouse Model of Ventricular Preexcitation and Atrioventricular Reentrant Tachycardia Induced by an AMP-Activated Protein Kinase Loss-of-Function Mutation Responsible for Wolff-Parkinson-White Syndrome , 2005, Circulation.
[23] S. Eckert,et al. [Glucose metabolism]. , 2005, Zeitschrift fur Kardiologie.
[24] Sanjoy Ghosh,et al. The metabolic "switch" AMPK regulates cardiac heparin-releasable lipoprotein lipase. , 2005, American journal of physiology. Endocrinology and metabolism.
[25] S. Kihara,et al. Adiponectin-mediated modulation of hypertrophic signals in the heart , 2004, Nature Medicine.
[26] G. Lopaschuk,et al. gAd-globular Head Domain of Adiponectin Increases Fatty Acid Oxidation in Newborn Rabbit Hearts* , 2004, Journal of Biological Chemistry.
[27] M. Birnbaum,et al. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. , 2004, The Journal of clinical investigation.
[28] D. Hardie,et al. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR. , 2004, American journal of physiology. Endocrinology and metabolism.
[29] Anita Y. M. Chan,et al. Activation of AMP-activated Protein Kinase Inhibits Protein Synthesis Associated with Hypertrophy in the Cardiac Myocyte* , 2004, Journal of Biological Chemistry.
[30] M. Latronico,et al. Regulation of Cell Size and Contractile Function by AKT in Cardiomyocytes , 2004, Annals of the New York Academy of Sciences.
[31] David Carling,et al. Thr2446 Is a Novel Mammalian Target of Rapamycin (mTOR) Phosphorylation Site Regulated by Nutrient Status* , 2004, Journal of Biological Chemistry.
[32] Christopher G. Proud,et al. A Novel mTOR-Regulated Phosphorylation Site in Elongation Factor 2 Kinase Modulates the Activity of the Kinase and Its Binding to Calmodulin , 2004, Molecular and Cellular Biology.
[33] G. Lopaschuk,et al. Fatty Acid Translocase/CD36 Deficiency Does Not Energetically or Functionally Compromise Hearts Before or After Ischemia , 2004, Circulation.
[34] C. Proud,et al. Stimulation of the AMP-activated Protein Kinase Leads to Activation of Eukaryotic Elongation Factor 2 Kinase and to Its Phosphorylation at a Novel Site, Serine 398* , 2004, Journal of Biological Chemistry.
[35] K. Shimamoto,et al. Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection. , 2004, Cardiovascular research.
[36] G. Hjälm,et al. Expression profiling of the γ-subunit isoforms of AMP-activated protein kinase suggests a major role for γ3 in white skeletal muscle , 2004 .
[37] Peter Schjerling,et al. Knockout of the α2 but Not α1 5′-AMP-activated Protein Kinase Isoform Abolishes 5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranosidebut Not Contraction-induced Glucose Uptake in Skeletal Muscle* , 2004, Journal of Biological Chemistry.
[38] B. Kemp,et al. Intrasteric control of AMPK via the γ1 subunit AMP allosteric regulatory site , 2004 .
[39] D. Kelly,et al. Gene Regulatory Mechanisms Governing Energy Metabolism during Cardiac Hypertrophic Growth , 2002, Heart Failure Reviews.
[40] G. Lopaschuk,et al. Energy Metabolism in the Hypertrophied Heart , 2002, Heart Failure Reviews.
[41] H. Taegtmeyer. Genetics of Energetics: Transcriptional Responses in Cardiac Metabolism , 2000, Annals of Biomedical Engineering.
[42] E. Olson,et al. Cardiac hypertrophy: the good, the bad, and the ugly. , 2003, Annual review of physiology.
[43] K. Inoki,et al. TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.
[44] D. Vertommen,et al. Myocardial Ischemia and Increased Heart Work Modulate the Phosphorylation State of Eukaryotic Elongation Factor-2* , 2003, Journal of Biological Chemistry.
[45] I. Shiojima,et al. Akt Activity Negatively Regulates Phosphorylation of AMP-activated Protein Kinase in the Heart* , 2003, Journal of Biological Chemistry.
[46] H. Watkins,et al. Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: implications for kinase function and disease pathogenesis. , 2003, Journal of molecular and cellular cardiology.
[47] J. Seidman,et al. Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiac hypertrophy and Wolff-Parkinson-White syndrome. , 2003, Journal of the American College of Cardiology.
[48] N. Fujii,et al. Glucose Metabolism and Energy Homeostasis in Mouse Hearts Overexpressing Dominant Negative α2 Subunit of AMP-activated Protein Kinase* , 2003, Journal of Biological Chemistry.
[49] R. Hannan,et al. Cardiac hypertrophy: A matter of translation , 2003, Clinical and experimental pharmacology & physiology.
[50] A. Bonen,et al. Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. , 2003, Diabetes.
[51] Ferhaan Ahmad,et al. Transgenic Mice Overexpressing Mutant PRKAG2 Define the Cause of Wolff-Parkinson-White Syndrome in Glycogen Storage Cardiomyopathy , 2003, Circulation.
[52] G. Shulman,et al. Physiological role of AMP-activated protein kinase in the heart: graded activation during exercise. , 2003, American journal of physiology. Endocrinology and metabolism.
[53] J. James,et al. A Novel Domain in AMP-Activated Protein Kinase Causes Glycogen Storage Bodies Similar to Those Seen in Hereditary Cardiac Arrhythmias , 2003, Current Biology.
[54] P. Light,et al. Constitutively Active Adenosine Monophosphate–Activated Protein Kinase Regulates Voltage-Gated Sodium Channels in Ventricular Myocytes , 2003, Circulation.
[55] D. Pipeleers,et al. AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. , 2003, Journal of molecular endocrinology.
[56] B. Lerman,et al. Molecular Genetic Analysis of PRKAG2 in Sporadic Wolff‐Parkinson‐White Syndrome , 2003, Journal of cardiovascular electrophysiology.
[57] M. Gollob. Glycogen storage disease as a unifying mechanism of disease in the PRKAG2 cardiac syndrome. , 2001, Biochemical Society transactions.
[58] G. Lopaschuk,et al. AMP-activated protein kinase regulation of fatty acid oxidation in the ischaemic heart. , 2001, Biochemical Society transactions.
[59] B. Viollet,et al. The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. , 2003, The Journal of clinical investigation.
[60] D. Carling,et al. Functional Analysis of Mutations in the γ2 Subunit of AMP-activated Protein Kinase Associated with Cardiac Hypertrophy and Wolff-Parkinson-White Syndrome* , 2002, The Journal of Biological Chemistry.
[61] C. Proud,et al. ATP depletion increases phosphorylation of elongation factor eEF2 in adult cardiomyocytes independently of inhibition of mTOR signalling , 2002, FEBS letters.
[62] L. Bertrand,et al. The stimulation of heart glycolysis by increased workload does not require AMP‐activated protein kinase but a wortmannin‐sensitive mechanism , 2002, FEBS letters.
[63] C. Kahn,et al. Akt Signaling Mediates Postnatal Heart Growth in Response to Insulin and Nutritional Status* , 2002, The Journal of Biological Chemistry.
[64] M. Rider,et al. Sustained activation of AMP‐activated protein kinase induces c‐Jun N‐terminal kinase activation and apoptosis in liver cells , 2002, FEBS letters.
[65] P. Kang,et al. Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice , 2002, Molecular and Cellular Biology.
[66] J. Seidman,et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. , 2002, The Journal of clinical investigation.
[67] Y. Hellsten,et al. Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. , 2002, Diabetes.
[68] J. Balschi,et al. The Relationship between AMP-activated Protein Kinase Activity and AMP Concentration in the Isolated Perfused Rat Heart* , 2002, The Journal of Biological Chemistry.
[69] J. Seger,et al. Novel PRKAG2 Mutation Responsible for the Genetic Syndrome of Ventricular Preexcitation and Conduction System Disease With Childhood Onset and Absence of Cardiac Hypertrophy , 2001, Circulation.
[70] B. Kemp,et al. Malonyl-CoA decarboxylase is not a substrate of AMP-activated protein kinase in rat fast-twitch skeletal muscle or an islet cell line. , 2001, Archives of biochemistry and biophysics.
[71] R. Bartrons,et al. Adenosine monophosphate–activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia‐reperfusion injury in the rat , 2001, Hepatology.
[72] H. Katus,et al. Cardiomyopathies: from genetics to the prospect of treatment , 2001, The Lancet.
[73] L. Fananapazir,et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. , 2001, The New England journal of medicine.
[74] L. Goodyear,et al. Increased Adenosine Monophosphate–Activated Protein Kinase Activity in Rat Hearts With Pressure-Overload Hypertrophy , 2001, Circulation.
[75] G. Lopaschuk,et al. Regulation of myocardial fatty acid oxidation by substrate supply. , 2001, American journal of physiology. Heart and circulatory physiology.
[76] L. Bertrand,et al. Insulin antagonizes AMP‐activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides , 2001, FEBS letters.
[77] B. Kemp,et al. An activating mutation in the γ1 subunit of the AMP‐activated protein kinase , 2001 .
[78] H. Watkins,et al. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. , 2001, Human molecular genetics.
[79] T. Dresselaers,et al. No-Flow Ischemia Inhibits Insulin Signaling in Heart by Decreasing Intracellular pH , 2001, Circulation research.
[80] T. Lang,et al. Molecular cloning, genomic organization, and mapping of PRKAG2, a heart abundant gamma2 subunit of 5'-AMP-activated protein kinase, to human chromosome 7q36. , 2000, Genomics.
[81] D. Carling,et al. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia , 2000, Current Biology.
[82] B. Rodrigues,et al. Hypertrophied rat hearts are less responsive to the metabolic and functional effects of insulin. , 2000, American journal of physiology. Endocrinology and metabolism.
[83] M. Prentki,et al. Activation of Malonyl-CoA Decarboxylase in Rat Skeletal Muscle by Contraction and the AMP-activated Protein Kinase Activator 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside* , 2000, The Journal of Biological Chemistry.
[84] B. Lorell,et al. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. , 2000, Circulation.
[85] C. Rogel-Gaillard,et al. A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. , 2000, Science.
[86] D. Carling,et al. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. , 2000, The Biochemical journal.
[87] L. Buja,et al. Palmitate-mediated alterations in the fatty acid metabolism of rat neonatal cardiac myocytes. , 2000, Journal of molecular and cellular cardiology.
[88] Heinrich Taegtmeyer,et al. Regulation of fatty acid oxidation of the heart by MCD and ACC during contractile stimulation. , 1999, American journal of physiology. Endocrinology and metabolism.
[89] G. Shulman,et al. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. , 1999, The American journal of physiology.
[90] G. Lopaschuk,et al. Fatty acid oxidation in the reperfused ischemic heart. , 1999, The American journal of the medical sciences.
[91] G. Lopaschuk,et al. Glucose utilization and glycogen turnover are accelerated in hypertrophied rat hearts during severe low-flow ischemia. , 1999, Journal of molecular and cellular cardiology.
[92] G. Lopaschuk,et al. Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation. , 1998, American journal of physiology. Heart and circulatory physiology.
[93] A. Edelman,et al. Components of a Calmodulin-dependent Protein Kinase Cascade , 1998, The Journal of Biological Chemistry.
[94] A. Clerk,et al. Cellular mechanisms of cardiac hypertrophy , 1998, Journal of Molecular Medicine.
[95] C. Thornton,et al. Identification of a Novel AMP-activated Protein Kinase β Subunit Isoform That Is Highly Expressed in Skeletal Muscle* , 1998, The Journal of Biological Chemistry.
[96] D. Hardie,et al. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. , 1997, American journal of physiology. Endocrinology and metabolism.
[97] G. Lopaschuk,et al. Insulin inhibition of 5' adenosine monophosphate-activated protein kinase in the heart results in activation of acetyl coenzyme A carboxylase and inhibition of fatty acid oxidation. , 1997, Metabolism: clinical and experimental.
[98] B. Kemp,et al. Contraction-induced Changes in Acetyl-CoA Carboxylase and 5′-AMP-activated Kinase in Skeletal Muscle* , 1997, The Journal of Biological Chemistry.
[99] G. Lopaschuk,et al. Upregulation of 5'-AMP-activated protein kinase is responsible for the increase in myocardial fatty acid oxidation rates following birth in the newborn rabbit. , 1997, Circulation research.
[100] M. Palacín,et al. Insulin-induced Recruitment of Glucose Transporter 4 (GLUT4) and GLUT1 in Isolated Rat Cardiac Myocytes , 1997, The Journal of Biological Chemistry.
[101] D. Hardie,et al. The AMP-activated protein kinase--fuel gauge of the mammalian cell? , 1997, European journal of biochemistry.
[102] Bin Liu,et al. Cardiac efficiency is improved after ischemia by altering both the source and fate of protons. , 1996, Circulation research.
[103] G. Lopaschuk,et al. Recovery of glycolysis and oxidative metabolism during postischemic reperfusion of hypertrophied rat hearts. , 1996, The American journal of physiology.
[104] Bruce E. Kemp,et al. Regulation of 5′-AMP-activated Protein Kinase Activity by the Noncatalytic β and γ Subunits* , 1996, The Journal of Biological Chemistry.
[105] L. Witters,et al. Characterization of 5'AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. , 1996, Biochimica et biophysica acta.
[106] D. Carling,et al. Characterization of AMP-activated Protein Kinase and Subunits , 1996, The Journal of Biological Chemistry.
[107] J. Scott,et al. Characterization of AMP-activated protein kinase beta and gamma subunits. Assembly of the heterotrimeric complex in vitro. , 1996, The Journal of biological chemistry.
[108] B. Kemp,et al. Non-catalytic - and -Subunit Isoforms of the 5′-AMP-activated Protein Kinase (*) , 1996, The Journal of Biological Chemistry.
[109] G. Radda,et al. Activation of glycogen phosphorylase and glycogenolysis in rat skeletal muscle by AICAR — an activator of AMP‐activated protein kinase , 1996, FEBS letters.
[110] B. Kemp,et al. Mammalian AMP-activated Protein Kinase Subfamily (*) , 1996, The Journal of Biological Chemistry.
[111] G. Lopaschuk,et al. Increased cardiac fatty acid uptake with dobutamine infusion in swine is accompanied by a decrease in malonyl CoA levels. , 1996, Cardiovascular research.
[112] G. Lopaschuk,et al. High Rates of Fatty Acid Oxidation during Reperfusion of Ischemic Hearts Are Associated with a Decrease in Malonyl-CoA Levels Due to an Increase in 5′-AMP-activated Protein Kinase Inhibition of Acetyl-CoA Carboxylase (*) , 1995, The Journal of Biological Chemistry.
[113] S. Donnelly,et al. Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. , 1994, The Journal of clinical investigation.
[114] J. English,et al. Calcium overload during reperfusion is accelerated in isolated hypertrophied rat hearts. , 1994, Journal of molecular and cellular cardiology.
[115] B. Kemp,et al. Mammalian 5'-AMP-activated protein kinase non-catalytic subunits are homologs of proteins that interact with yeast Snf1 protein kinase. , 1994, The Journal of biological chemistry.
[116] G. Lopaschuk,et al. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. , 1994, The American journal of physiology.
[117] P. Penkoske,et al. Plasma fatty acid levels in infants and adults after myocardial ischemia. , 1994, American heart journal.
[118] L. Witters,et al. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. , 1993, The Journal of biological chemistry.
[119] L. Opie,et al. Protons in ischemia: where do they come from; where do they go to? , 1991, Journal of molecular and cellular cardiology.
[120] G. D. Thomas,et al. Increased ischemic injury but decreased hypoxic injury in hypertrophied rat hearts. , 1990, Circulation research.
[121] W. Gaasch,et al. Tolerance of the hypertrophic heart to ischemia. Studies in compensated and failing dog hearts with pressure overload hypertrophy. , 1990, Circulation.
[122] K. Thampy. Formation of malonyl coenzyme A in rat heart. Identification and purification of an isozyme of A carboxylase from rat heart. , 1989, The Journal of biological chemistry.
[123] D. Hardie,et al. The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase. , 1989, Biochimica et biophysica acta.
[124] S. Ayres,et al. Metabolic response of the heart in acute myocardial infarction in man. , 1978, The American journal of cardiology.
[125] M. Oliver,et al. Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction. , 1968, Lancet.
[126] P. J. Randle,et al. THE GLUCOSE FATTY ACID CYCLE IN OBESITY AND MATURITY ONSET DIABETES MELLITUS , 1965, Annals of the New York Academy of Sciences.
[127] P. Véghelyi. EMERGENCY HYPOTHERMIC IN MENINGOCOCCAL MENINGITIS. , 1965, Lancet.